Cargando…
Aldehyde dehydrogenase 2*2 knock-in mice show increased reactive oxygen species production in response to cisplatin treatment
BACKGROUND: The aldehyde dehydrogenase (ALDH) enzyme family metabolizes and detoxifies both exogenous and endogenous aldehydes. Since chemotherapeutic agents, such as cisplatin, generate cytotoxic aldehydes and oxidative stress, and chemoresistant cancer cells express high levels of ALDH enzymes, we...
Autores principales: | Kim, Jeewon, Chen, Che-Hong, Yang, Jieying, Mochly-Rosen, Daria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439151/ https://www.ncbi.nlm.nih.gov/pubmed/28532411 http://dx.doi.org/10.1186/s12929-017-0338-8 |
Ejemplares similares
-
Mitochondrial aldehyde dehydrogenase and cardiac diseases
por: Chen, Che-Hong, et al.
Publicado: (2010) -
Targeting aldehyde dehydrogenase activity in head and neck squamous cell carcinoma with a novel small molecule inhibitor
por: Kim, Jeewon, et al.
Publicado: (2017) -
Aldehyde dehydrogenase 2 activation and coevolution of its εPKC-mediated phosphorylation sites
por: Nene, Aishwarya, et al.
Publicado: (2017) -
Development of Selective Inhibitors
for Aldehyde Dehydrogenases
Based on Substituted Indole-2,3-diones
por: Kimble-Hill, Ann C., et al.
Publicado: (2014) -
Aldehyde dehydrogenase 2 activity and aldehydic load contribute to neuroinflammation and Alzheimer’s disease related pathology
por: Joshi, Amit U., et al.
Publicado: (2019)